Dodge & Cox’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Dodge & Cox's NVO Position: Q3 2026 in Review
Dodge & Cox reduced its Novo Nordisk (NVO) stake by 0.22% in Q3 2026, selling an estimated $2.06M and leaving 20,352,460 shares worth $772M. The position accounts for 0.41% of the portfolio, ranked #72.
Dodge & Cox first reported a position in NVO in Q1 2026 and has held it in 3 quarters since. The position peaked at $978M in Q2 2026. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Dodge & Cox held 20,352,460 shares of Novo Nordisk worth $772M as of Q3 2026.
- Dodge & Cox sold 44,650 Novo Nordisk shares in Q3 2026, an estimated $2.06M.
- Novo Nordisk made up 0.41% of Dodge & Cox's portfolio in Q3 2026, its #72 holding.
- Dodge & Cox first reported a position in Novo Nordisk in Q1 2026 and has held it in 3 quarters since.
- Dodge & Cox's Novo Nordisk position peaked at $978M in Q2 2026.
- 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Dodge & Cox's 13F filing for Q3 2026, filed 13 Nov 2026.